Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 10:8:333.
doi: 10.3389/fnagi.2016.00333. eCollection 2016.

The Walnuts and Healthy Aging Study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging

Sujatha Rajaram  1 , Cinta Valls-Pedret  2 , Montserrat Cofán  2 , Joan Sabaté  1 , Mercè Serra-Mir  2 , Ana M Pérez-Heras  2 , Adam Arechiga  3 , Ricardo P Casaroli-Marano  4 , Socorro Alforja  4 , Aleix Sala-Vila  2 , Mónica Doménech  2 , Irene Roth  2 , Tania M Freitas-Simoes  5 , Carlos Calvo  2 , Anna López-Illamola  2 , Ella Haddad  1 , Edward Bitok  1 , Natalie Kazzi  1 , Lynnley Huey  1 , Joseph Fan  6 , Emilio Ros  2
Affiliations

The Walnuts and Healthy Aging Study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging

Sujatha Rajaram et al. Front Aging Neurosci. .

Abstract

Introduction: An unwanted consequence of population aging is the growing number of elderly at risk of neurodegenerative disorders, including dementia and macular degeneration. As nutritional and behavioral changes can delay disease progression, we designed the Walnuts and Healthy Aging (WAHA) study, a two-center, randomized, 2-year clinical trial conducted in free-living, cognitively healthy elderly men and women. Our interest in exploring the role of walnuts in maintaining cognitive and retinal health is based on extensive evidence supporting their cardio-protective and vascular health effects, which are linked to bioactive components, such as n-3 fatty acids and polyphenols. Methods: The primary aim of WAHA is to examine the effects of ingesting walnuts daily for 2 years on cognitive function and retinal health, assessed with a battery of neuropsychological tests and optical coherence tomography, respectively. All participants followed their habitual diet, adding walnuts at 15% of energy (≈30-60 g/day) (walnut group) or abstaining from walnuts (control group). Secondary outcomes include changes in adiposity, blood pressure, and serum and urinary biomarkers in all participants and brain magnetic resonance imaging in a subset. Results: From May 2012 to May 2014, 708 participants (mean age 69 years, 68% women) were randomized. The study ended in May 2016 with a 90% retention rate. Discussion: The results of WAHA might provide high-level evidence of the benefit of regular walnut consumption in delaying the onset of age-related cognitive impairment and retinal pathology. The findings should translate into public health policy and sound recommendations to the general population (ClinicalTrials.gov identifier NCT01634841).

Keywords: Alzheimer’s disease; age-related macular degeneration; aging; cognitive decline; dietary intervention; randomized trial; walnuts.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Design of the Walnuts and Healthy Aging (WAHA) study.
FIGURE 2
FIGURE 2
Recruitment and participant allocation.
FIGURE 3
FIGURE 3
Baseline biomarkers of adherence to walnuts and change after 1 year by intervention group. RBC, red blood cells. In red, mean and 95% CI (ANCOVA, adjusting for center, age, and sex). (A) Percentage of total fatty acids in RBC at baseline. Values are 0.233 (0.218–0.247) and 0.221 (0.206–0.236) for the walnut and control groups, respectively. (B) Percentage of change of total fatty acids in RBC after 1 year. Values are 0.163 (0.144–0.183) and 0.019 (0.001–0.039) for the walnut and control groups, respectively.
See this image and copyright information in PMC

References

    1. Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AReds report No. 8. Arch. Ophthalmol. 119 1417–1436. 10.1001/archopht.119.10.1417 - DOI - PMC - PubMed
    1. Alzheimer’s Association (2015). Alzheimer’s disease facts and figures. Alzheimers Dement. 11 332–384. 10.1016/j.jalz.2015.02.003 - DOI - PubMed
    1. Amirul Islam F. M., Chong E. W., Hodge A. M., Guymer R. H., Aung K. Z., Makeyeva G. A., et al. (2014). Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study. Ophthalmology 121 1428–1434. 10.1016/j.ophtha.2014.01.002 - DOI - PubMed
    1. Barbour J. A., Howe P. R., Buckley J. D., Bryan J., Coates A. M. (2014). Nut consumption for vascular health and cognitive function. Nutr. Res. Rev. 27 131–158. 10.1017/S0954422414000079 - DOI - PubMed
    1. Barnes J. L., Tian M., Edens N. K., Morris M. C. (2014). Consideration of nutrient levels in studies of cognitive decline. Nutr. Rev. 72 707–719. 10.1111/nure.12144 - DOI - PubMed

Associated data